Neil Hukriede, PhD

Acute kidney injury (AKI) is associated with high mortality and morbidity and AKI survivors often develop end stage renal disease. At present, there are no established therapies to prevent renal injury or accelerate the rate of renal recovery following AKI.  The Hukriede lab performs chemical screens to identify compounds that enhance kidney regeneration by increasing the rate of renal recovery and decreasing fibrosis.